Lumida
/INVA
⌘K
Innoviva Inc

Innoviva Inc

INVA
$21.71USD-2.25%-0.50 today

MARKET CAP

1.6B

P/E (TTM)

5.8x

FWD P/E

9.6x

DAY RANGE

$22 – $22

52W RANGE

$17
$25

AI Summary

Stalk
TrimMedium

INVA is locked in a Stage 4 decline with confirmed lower highs/lower lows and a bearish support failure pattern. Though oversold, Mean Reversion Eligible is No, so no countertrend buying flag. The medium-term bias remains bearish, favoring sells only on rallies into the declining 9/21 EMA zone. Short-term timing is unfavorable due to oversold extension, so execution should be deferred (Trim) rather than immediate selling.

  • Dr. Reddy’s partnership extends XACDURO royalties across international markets.
  • BTIG maintains Buy/$42 target; median $39 price target implies +65% upside.
  • Q1 EPS of –$0.05 missed $0.40 estimate, highlighting execution issues.
Full analysis →
Insider Trades30 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
May 20, 2026SellINVAStephen BassoChief Financial Officer559$22.24$1.6B-13.66%+31.42%$12.4K-0.63%Trim
May 20, 2026SellINVAMarianne ZhenChief Accounting Officer1,127$22.24$1.6B-13.66%+31.42%$25.1K-1.92%Trim
May 20, 2026SellINVAPavel RaifeldChief Executive Officer1,130$22.24$1.6B-13.66%+31.42%$25.1K-0.39%Trim
Feb 20, 2026SellINVAStephen BassoChief Financial Officer1,244$23.39$1.6B-13.66%+31.42%$29.1K-2.43%Trim
Feb 20, 2026SellINVAMarianne ZhenChief Accounting Officer2,460$23.39$1.6B-13.66%+31.42%$57.5K-5.09%Trim
Feb 20, 2026SellINVAPavel RaifeldChief Executive Officer2,986$23.39$1.6B-13.66%+31.42%$69.8K-1.84%Trim
Nov 20, 2025SellINVAStephen BassoChief Financial Officer237$21.16$1.6B-13.66%+31.42%$5.0K-0.46%Trim
Nov 20, 2025SellINVAMarianne ZhenChief Accounting Officer992$21.16$1.6B-13.66%+31.42%$21.0K-2.01%Trim
Nov 3, 2025BuyINVAStephen BassoChief Financial Officer27,609$18.11$1.6B-13.66%+31.42%$500.0K+118.59%Trim
Aug 20, 2025SellINVAStephen BassoChief Financial Officer237$19.95$1.6B-13.66%+31.42%$4.7K-1.01%Trim
Aug 20, 2025SellINVAMarianne ZhenChief Accounting Officer991$19.95$1.6B-13.66%+31.42%$19.8K-1.97%Trim
May 20, 2025SellINVAStephen BassoChief Financial Officer237$18.78$1.6B-13.66%+31.42%$4.5K-1.00%Trim
May 20, 2025SellINVAMarianne ZhenChief Accounting Officer992$18.78$1.6B-13.66%+31.42%$18.6K-1.93%Trim
Feb 24, 2025BuyINVAMarianne ZhenChief Accounting Officer8,938$18.08$1.6B-13.66%+31.42%$161.6K+6.59%Trim
Feb 24, 2025BuyINVAStephen BassoChief Financial Officer10,569$18.08$1.6B-13.66%+31.42%$191.1K+3.66%Trim
Feb 20, 2025SellINVAStephen BassoChief Financial Officer1,106$18.07$1.6B-13.66%+31.42%$20.0K-8.55%Trim
Feb 20, 2025SellINVAMarianne ZhenChief Accounting Officer2,565$18.07$1.6B-13.66%+31.42%$46.3K-5.71%Trim
Nov 20, 2024SellINVAMarianne ZhenChief Accounting Officer976$19.15$1.6B-13.66%+31.42%$18.7K-2.13%Trim
Aug 20, 2024SellINVAMarianne ZhenChief Accounting Officer975$18.49$1.6B-13.66%+31.42%$18.0K-2.09%Trim
May 20, 2024SellINVAMatthew Ronsheim268$16.13$1.6B-13.66%+31.42%$4.3K-0.66%Trim
May 20, 2024SellINVAMarianne ZhenChief Accounting Officer976$16.13$1.6B-13.66%+31.42%$15.7K-2.05%Trim
Mar 5, 2024BuyINVAMarianne ZhenChief Accounting Officer10,752$14.88$1.6B-13.66%+31.42%$160.0K+10.77%Trim
Mar 5, 2024BuyINVAStephen BassoChief Financial Officer12,096$14.88$1.6B-13.66%+31.42%$180.0K+6.88%Trim
Mar 5, 2024BuyINVAMatthew Ronsheim12,768$14.88$1.6B-13.66%+31.42%$190.0K+8.60%Trim
Feb 20, 2024SellINVAMatthew Ronsheim807$15.80$1.6B-13.66%+31.42%$12.8K-2.80%Trim
Feb 20, 2024SellINVAMarianne ZhenChief Accounting Officer2,862$15.80$1.6B-13.66%+31.42%$45.2K-7.21%Trim
Jan 18, 2024SellINVAMatthew Ronsheim1,600$16.05$1.6B-13.66%+31.42%$25.7K-1.30%Trim
Nov 20, 2023SellINVAMarianne ZhenChief Accounting Officer784$13.62$1.6B-13.66%+31.42%$10.7K-1.94%Trim
Nov 15, 2023SellINVAMarianne ZhenChief Accounting Officer10,994$13.99$1.6B-13.66%+31.42%$153.8K-11.37%Trim
Aug 18, 2023SellINVAMarianne ZhenChief Accounting Officer785$13.64$1.6B-13.66%+31.42%$10.7K-1.51%Trim